{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T12:33:25Z","timestamp":1759667605276},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,8,11]],"date-time":"2018-08-11T00:00:00Z","timestamp":1533945600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00428-018-2404-3","type":"journal-article","created":{"date-parts":[[2018,8,11]],"date-time":"2018-08-11T00:36:23Z","timestamp":1533947783000},"page":"607-614","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Nuclear loss and cytoplasmic expression of androgen receptor in penile carcinomas: role as a driver event and as a prognosis factor"],"prefix":"10.1007","volume":"473","author":[{"given":"Hellen","family":"Kuasne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateus C.","family":"Barros-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1bio A.","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra A.","family":"Drigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristovam","family":"Scapulatempo-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliney F.","family":"Faria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia R.","family":"Rogatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,11]]},"reference":[{"issue":"12","key":"2404_CR1","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1210\/me.2007-0223","volume":"21","author":"SM Dehm","year":"2007","unstructured":"Dehm SM, Tindall DJ (2007) Androgen receptor structural and functional elements: role and regulation in prostate cancer. Mol Endocrinol 21(12):2855\u20132863. \n                    https:\/\/doi.org\/10.1210\/me.2007-0223","journal-title":"Mol Endocrinol"},{"key":"2404_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-physiol-021909-135917","volume":"72","author":"P Huang","year":"2010","unstructured":"Huang P, Chandra V, Rastinejad F (2010) Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics. Annu Rev Physiol 72:247\u2013272. \n                    https:\/\/doi.org\/10.1146\/annurev-physiol-021909-135917","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"2404_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0006-291X(88)81214-2","volume":"153","author":"J Trapman","year":"1988","unstructured":"Trapman J, Klaassen P, Kuiper GG, van der Korput JA, Faber PW, van Rooij HC, Geurts van Kessel A, Voorhorst MM, Mulder E, Brinkmann AO (1988) Cloning, structure and expression of a cDNA encoding the human androgen receptor. Biochem Biophys Res Commun 153(1):241\u2013248","journal-title":"Biochem Biophys Res Commun"},{"issue":"4850","key":"2404_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1126\/science.3353727","volume":"240","author":"DB Lubahn","year":"1988","unstructured":"Lubahn DB, Joseph DR, Sullivan PM, Willard HF, French FS, Wilson EM (1988) Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 240(4850):327\u2013330","journal-title":"Science"},{"key":"2404_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0083-6729(08)60938-3","volume":"55","author":"AK Roy","year":"1999","unstructured":"Roy AK, Lavrovsky Y, Song CS, Chen S, Jung MH, Velu NK, Bi BY, Chatterjee B (1999) Regulation of androgen action. Vitam Horm 55:309\u2013352","journal-title":"Vitam Horm"},{"issue":"8","key":"2404_CR6","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s00018-003-2309-3","volume":"60","author":"HJ Lee","year":"2003","unstructured":"Lee HJ, Chang C (2003) Recent advances in androgen receptor action. Cell Mol Life Sci 60(8):1613\u20131622. \n                    https:\/\/doi.org\/10.1007\/s00018-003-2309-3","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"2404_CR7","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1210\/me.2002-0070","volume":"16","author":"CA Heinlein","year":"2002","unstructured":"Heinlein CA, Chang C (2002) The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol Endocrinol 16(10):2181\u20132187. \n                    https:\/\/doi.org\/10.1210\/me.2002-0070","journal-title":"Mol Endocrinol"},{"key":"2404_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fendo.2017.00002","volume":"8","author":"JK Leung","year":"2017","unstructured":"Leung JK, Sadar MD (2017) Non-genomic actions of the androgen receptor in prostate cancer. Front Endocrinol (Lausanne) 8:2. \n                    https:\/\/doi.org\/10.3389\/fendo.2017.00002","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2404_CR9","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.cellsig.2016.01.013","volume":"28","author":"JC Zarif","year":"2016","unstructured":"Zarif JC, Miranti CK (2016) The importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistance. Cell Signal 28(5):348\u2013356. \n                    https:\/\/doi.org\/10.1016\/j.cellsig.2016.01.013","journal-title":"Cell Signal"},{"issue":"3","key":"2404_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3978\/j.issn.2223-4683.2013.09.15","volume":"2","author":"K Eisermann","year":"2013","unstructured":"Eisermann K, Wang D, Jing Y, Pascal LE, Wang Z (2013) Androgen receptor gene mutation, rearrangement, polymorphism. Transl Androl Urol 2(3):137\u2013147. \n                    https:\/\/doi.org\/10.3978\/j.issn.2223-4683.2013.09.15","journal-title":"Transl Androl Urol"},{"issue":"5","key":"2404_CR11","doi-asserted-by":"publisher","first-page":"101042831769225","DOI":"10.1177\/1010428317692259","volume":"39","author":"J Hu","year":"2017","unstructured":"Hu J, Wang G, Sun T (2017) Dissecting the roles of the androgen receptor in prostate cancer from molecular perspectives. Tumour Biol 39(5):1010428317692259. \n                    https:\/\/doi.org\/10.1177\/1010428317692259","journal-title":"Tumour Biol"},{"issue":"3","key":"2404_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.currproblcancer.2015.03.010","volume":"39","author":"M Christodoulidou","year":"2015","unstructured":"Christodoulidou M, Sahdev V, Houssein S, Muneer A (2015) Epidemiology of penile cancer. Curr Probl Cancer 39(3):126\u2013136. \n                    https:\/\/doi.org\/10.1016\/j.currproblcancer.2015.03.010","journal-title":"Curr Probl Cancer"},{"issue":"22","key":"2404_CR13","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1093\/jnci\/87.22.1705","volume":"87","author":"L Gregoire","year":"1995","unstructured":"Gregoire L, Cubilla AL, Reuter VE, Haas GP, Lancaster WD (1995) Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma. J Natl Cancer Inst 87(22):1705\u20131709","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"2404_CR14","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jcp.2008.063149","volume":"62","author":"C Miralles-Guri","year":"2009","unstructured":"Miralles-Guri C, Bruni L, Cubilla AL, Castellsague X, Bosch FX, de Sanjose S (2009) Human papillomavirus prevalence and type distribution in penile carcinoma. J Clin Pathol 62(10):870\u2013878. \n                    https:\/\/doi.org\/10.1136\/jcp.2008.063149","journal-title":"J Clin Pathol"},{"issue":"1","key":"2404_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/PAS.0b013e3181c76a49","volume":"34","author":"AL Cubilla","year":"2010","unstructured":"Cubilla AL, Lloveras B, Alejo M, Clavero O, Chaux A, Kasamatsu E, Velazquez EF, Lezcano C, Monfulleda N, Tous S, Alemany L, Klaustermeier J, Munoz N, Quint W, de Sanjose S, Bosch FX (2010) The basaloid cell is the best tissue marker for human papillomavirus in invasive penile squamous cell carcinoma: a study of 202 cases from Paraguay. Am J Surg Pathol 34(1):104\u2013114. \n                    https:\/\/doi.org\/10.1097\/PAS.0b013e3181c76a49","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2404_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jaad.2012.05.029","volume":"68","author":"C Ferrandiz-Pulido","year":"2013","unstructured":"Ferrandiz-Pulido C, Masferrer E, de Torres I, Lloveras B, Hernandez-Losa J, Mojal S, Salvador C, Morote J, Ramon y Cajal S, Pujol RM, Garcia-Patos V, Toll A (2013) Identification and genotyping of human papillomavirus in a Spanish cohort of penile squamous cell carcinomas: correlation with pathologic subtypes, p16(INK4a) expression, and prognosis. J Am Acad Dermatol 68(1):73\u201382. \n                    https:\/\/doi.org\/10.1016\/j.jaad.2012.05.029","journal-title":"J Am Acad Dermatol"},{"key":"2404_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fonc.2014.00009","volume":"4","author":"BY Hernandez","year":"2014","unstructured":"Hernandez BY, Goodman MT, Unger ER, Steinau M, Powers A, Lynch CF, Cozen W, Saber MS, Peters ES, Wilkinson EJ, Copeland G, Hopenhayn C, Huang Y, Watson M, Altekruse SF, Lyu C, Saraiya M, Workgroup HPVToC (2014) Human papillomavirus genotype prevalence in invasive penile cancers from a registry-based United States population. Front Oncol 4:9. \n                    https:\/\/doi.org\/10.3389\/fonc.2014.00009","journal-title":"Front Oncol"},{"issue":"5","key":"2404_CR18","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.eururo.2015.12.007","volume":"69","author":"L Alemany","year":"2016","unstructured":"Alemany L, Cubilla A, Halec G, Kasamatsu E, Quiros B, Masferrer E, Tous S, Lloveras B, Hernandez-Suarez G, Lonsdale R, Tinoco L, Alejo M, Alvarado-Cabrero I, Laco J, Guimera N, Poblet E, Lombardi LE, Bergeron C, Clavero O, Shin HR, Ferrera A, Felix A, Germar J, Mandys V, Clavel C, Tzardi M, Pons LE, Wain V, Cruz E, Molina C, Mota JD, Jach R, Velasco J, Carrilho C, Lopez-Revilla R, Goodman MT, Quint WG, Castellsague X, Bravo I, Pawlita M, Munoz N, Bosch FX, de Sanjose S, group HVs (2016) Role of human papillomavirus in penile carcinomas worldwide. Eur Urol 69(5):953\u2013961. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2015.12.007","journal-title":"Eur Urol"},{"issue":"9","key":"2404_CR19","doi-asserted-by":"publisher","first-page":"15294","DOI":"10.18632\/oncotarget.14783","volume":"8","author":"H Kuasne","year":"2017","unstructured":"Kuasne H, Barros-Filho MC, Busso-Lopes A, Marchi FA, Pinheiro M, Munoz JJ, Scapulatempo-Neto C, Faria EF, Guimaraes GC, Lopes A, Trindade-Filho JC, Domingues MA, Drigo SA, Rogatto SR (2017) Integrative miRNA and mRNA analysis in penile carcinomas reveals markers and pathways with potential clinical impact. Oncotarget 8(9):15294\u201315306. \n                    https:\/\/doi.org\/10.18632\/oncotarget.14783","journal-title":"Oncotarget"},{"issue":"5","key":"2404_CR20","doi-asserted-by":"publisher","first-page":"791","DOI":"10.21037\/tau.2017.06.27","volume":"6","author":"LC Kidd","year":"2017","unstructured":"Kidd LC, Chaing S, Chipollini J, Giuliano AR, Spiess PE, Sharma P (2017) Relationship between human papillomavirus and penile cancer-implications for prevention and treatment. Transl Androl Urol 6(5):791\u2013802. \n                    https:\/\/doi.org\/10.21037\/tau.2017.06.27","journal-title":"Transl Androl Urol"},{"issue":"1","key":"2404_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1634\/theoncologist.2015-0241","volume":"21","author":"SM Ali","year":"2016","unstructured":"Ali SM, Pal SK, Wang K, Palma NA, Sanford E, Bailey M, He J, Elvin JA, Chmielecki J, Squillace R, Dow E, Morosini D, Buell J, Yelensky R, Lipson D, Frampton GM, Howley P, Ross JS, Stephens PJ, Miller VA (2016) Comprehensive genomic profiling of advanced penile carcinoma suggests a high frequency of clinically relevant genomic alterations. Oncologist 21(1):33\u201339. \n                    https:\/\/doi.org\/10.1634\/theoncologist.2015-0241","journal-title":"Oncologist"},{"issue":"2","key":"2404_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1158\/1940-6207.CAPR-14-0284","volume":"8","author":"AF Busso-Lopes","year":"2015","unstructured":"Busso-Lopes AF, Marchi FA, Kuasne H, Scapulatempo-Neto C, Trindade-Filho JC, de Jesus CM, Lopes A, Guimaraes GC, Rogatto SR (2015) Genomic profiling of human penile carcinoma predicts worse prognosis and survival. Cancer Prev Res (Phila) 8(2):149\u2013156. \n                    https:\/\/doi.org\/10.1158\/1940-6207.CAPR-14-0284","journal-title":"Cancer Prev Res (Phila)"},{"issue":"5","key":"2404_CR23","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1158\/1078-0432.CCR-14-1656","volume":"21","author":"A Feber","year":"2015","unstructured":"Feber A, Arya M, de Winter P, Saqib M, Nigam R, Malone PR, Tan WS, Rodney S, Lechner M, Freeman A, Jameson C, Muneer A, Beck S, Kelly JD (2015) Epigenetics markers of metastasis and HPV-induced tumorigenesis in penile cancer. Clin Cancer Res 21(5):1196\u20131206. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-1656","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2404_CR24","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/gcc.22274","volume":"54","author":"C Ferrandiz-Pulido","year":"2015","unstructured":"Ferrandiz-Pulido C, Hernandez-Losa J, Masferrer E, Vivancos A, Somoza R, Mares R, Valverde C, Salvador C, Placer J, Morote J, Pujol RM, Ramon y Cajal S, de Torres I, Toll A, Garcia-Patos V (2015) Identification of somatic gene mutations in penile squamous cell carcinoma. Genes Chromosom Cancer 54(10):629\u2013637. \n                    https:\/\/doi.org\/10.1002\/gcc.22274","journal-title":"Genes Chromosom Cancer"},{"issue":"2","key":"2404_CR25","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.juro.2016.01.115","volume":"196","author":"JM Hartz","year":"2016","unstructured":"Hartz JM, Engelmann D, Furst K, Marquardt S, Spitschak A, Goody D, Protzel C, Hakenberg OW, Putzer BM (2016) Integrated loss of miR-1\/miR-101\/miR-204 discriminates metastatic from nonmetastatic penile carcinomas and can predict patient outcome. J Urol 196(2):570\u2013578. \n                    https:\/\/doi.org\/10.1016\/j.juro.2016.01.115","journal-title":"J Urol"},{"key":"2404_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-015-0082-4","volume":"7","author":"H Kuasne","year":"2015","unstructured":"Kuasne H, Colus IM, Busso AF, Hernandez-Vargas H, Barros-Filho MC, Marchi FA, Scapulatempo-Neto C, Faria EF, Lopes A, Guimaraes GC, Herceg Z, Rogatto SR (2015) Genome-wide methylation and transcriptome analysis in penile carcinoma: uncovering new molecular markers. Clin Epigenetics 7:46. \n                    https:\/\/doi.org\/10.1186\/s13148-015-0082-4","journal-title":"Clin Epigenetics"},{"issue":"4","key":"2404_CR27","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1464-410X.2008.07697.x","volume":"102","author":"BK Kroon","year":"2008","unstructured":"Kroon BK, Leijte JA, van Boven H, Wessels LF, Velds A, Horenblas S, van\u2019t Veer LJ (2008) Microarray gene-expression profiling to predict lymph node metastasis in penile carcinoma. BJU Int 102(4):510\u2013515. \n                    https:\/\/doi.org\/10.1111\/j.1464-410X.2008.07697.x","journal-title":"BJU Int"},{"issue":"1","key":"2404_CR28","doi-asserted-by":"publisher","first-page":"6707","DOI":"10.1038\/s41598-017-06659-1","volume":"7","author":"FA Marchi","year":"2017","unstructured":"Marchi FA, Martins DC, Barros-Filho MC, Kuasne H, Busso Lopes AF, Brentani H, Trindade Filho JCS, Guimaraes GC, Faria EF, Scapulatempo-Neto C, Lopes A, Rogatto SR (2017) Multidimensional integrative analysis uncovers driver candidates and biomarkers in penile carcinoma. Sci Rep 7(1):6707. \n                    https:\/\/doi.org\/10.1038\/s41598-017-06659-1","journal-title":"Sci Rep"},{"issue":"24","key":"2404_CR29","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1158\/0008-5472.CAN-15-1004","volume":"75","author":"AS McDaniel","year":"2015","unstructured":"McDaniel AS, Hovelson DH, Cani AK, Liu CJ, Zhai Y, Zhang Y, Weizer AZ, Mehra R, Feng FY, Alva AS, Morgan TM, Montgomery JS, Siddiqui J, Sadis S, Bandla S, Williams PD, Cho KR, Rhodes DR, Tomlins SA (2015) Genomic profiling of penile squamous cell carcinoma reveals new opportunities for targeted therapy. Cancer Res 75(24):5219\u20135227. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1004","journal-title":"Cancer Res"},{"issue":"7","key":"2404_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131336","volume":"10","author":"L Zhang","year":"2015","unstructured":"Zhang L, Wei P, Shen X, Zhang Y, Xu B, Zhou J, Fan S, Hao Z, Shi H, Zhang X, Kong R, Xu L, Gao J, Zou D, Liang C (2015) MicroRNA expression profile in penile cancer revealed by next-generation small RNA sequencing. PLoS One 10(7):e0131336. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0131336","journal-title":"PLoS One"},{"issue":"1","key":"2404_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/gcc.1117","volume":"31","author":"G Alves","year":"2001","unstructured":"Alves G, Heller A, Fiedler W, Campos MM, Claussen U, Ornellas AA, Liehr T (2001) Genetic imbalances in 26 cases of penile squamous cell carcinoma. Genes Chromosom Cancer 31(1):48\u201353. \n                    https:\/\/doi.org\/10.1002\/gcc.1117","journal-title":"Genes Chromosom Cancer"},{"issue":"3 Pt 2","key":"2404_CR32","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1097\/00005392-199709000-00108","volume":"158","author":"LS Baskin","year":"1997","unstructured":"Baskin LS, Sutherland RS, DiSandro MJ, Hayward SW, Lipschutz J, Cunha GR (1997) The effect of testosterone on androgen receptors and human penile growth. J Urol 158(3 Pt 2):1113\u20131118","journal-title":"J Urol"},{"issue":"3","key":"2404_CR33","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/pcan.2016.17","volume":"19","author":"ES Antonarakis","year":"2016","unstructured":"Antonarakis ES, Armstrong AJ, Dehm SM, Luo J (2016) Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting. Prostate Cancer Prostatic Dis 19(3):231\u2013241. \n                    https:\/\/doi.org\/10.1038\/pcan.2016.17","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"2404_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1158\/1541-7786.MCR-16-0236","volume":"15","author":"Y Zhan","year":"2017","unstructured":"Zhan Y, Zhang G, Wang X, Qi Y, Bai S, Li D, Ma T, Sartor O, Flemington EK, Zhang H, Lee P, Dong Y (2017) Interplay between cytoplasmic and nuclear androgen receptor splice variants mediates castration resistance. Mol Cancer Res 15(1):59\u201368. \n                    https:\/\/doi.org\/10.1158\/1541-7786.MCR-16-0236","journal-title":"Mol Cancer Res"},{"issue":"Pt 7","key":"2404_CR35","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1242\/jcs.022103","volume":"121","author":"ML Cutress","year":"2008","unstructured":"Cutress ML, Whitaker HC, Mills IG, Stewart M, Neal DE (2008) Structural basis for the nuclear import of the human androgen receptor. J Cell Sci 121(Pt 7):957\u2013968. \n                    https:\/\/doi.org\/10.1242\/jcs.022103","journal-title":"J Cell Sci"},{"issue":"3","key":"2404_CR36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3978\/j.issn.2223-4683.2013.09.08","volume":"2","author":"C Lu","year":"2013","unstructured":"Lu C, Luo J (2013) Decoding the androgen receptor splice variants. Transl Androl Urol 2(3):178\u2013186. \n                    https:\/\/doi.org\/10.3978\/j.issn.2223-4683.2013.09.08","journal-title":"Transl Androl Urol"},{"issue":"4","key":"2404_CR37","doi-asserted-by":"publisher","first-page":"580","DOI":"10.4103\/1008-682X.178490","volume":"18","author":"J Luo","year":"2016","unstructured":"Luo J (2016) Development of AR-V7 as a putative treatment selection marker for metastatic castration-resistant prostate cancer. Asian J Androl 18(4):580\u2013585. \n                    https:\/\/doi.org\/10.4103\/1008-682X.178490","journal-title":"Asian J Androl"},{"issue":"4","key":"2404_CR38","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.urology.2005.10.026","volume":"67","author":"RS Campos","year":"2006","unstructured":"Campos RS, Lopes A, Guimaraes GC, Carvalho AL, Soares FA (2006) E-cadherin, MMP-2, and MMP-9 as prognostic markers in penile cancer: analysis of 125 patients. Urology 67(4):797\u2013802. \n                    https:\/\/doi.org\/10.1016\/j.urology.2005.10.026","journal-title":"Urology"},{"key":"2404_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12907-015-0003-7","volume":"15","author":"L Termini","year":"2015","unstructured":"Termini L, Fregnani JH, Boccardo E, da Costa WH, Longatto-Filho A, Andreoli MA, Costa MC, Lopes A, da Cunha IW, Soares FA, Villa LL, Guimaraes GC (2015) SOD2 immunoexpression predicts lymph node metastasis in penile cancer. BMC Clin Pathol 15:3. \n                    https:\/\/doi.org\/10.1186\/s12907-015-0003-7","journal-title":"BMC Clin Pathol"},{"key":"2404_CR40","doi-asserted-by":"publisher","unstructured":"Li H, Wang Z, Tang K, Zhou H, Liu H, Yan L, Guan W, Chen K, Xu H, Ye Z (2017) Prognostic value of androgen receptor splice variant 7 in the treatment of castration-resistant prostate cancer with next generation androgen receptor signal inhibition: a systematic review and meta-analysis. Eur Urol Focus. \n                    https:\/\/doi.org\/10.1016\/j.euf.2017.01.004","DOI":"10.1016\/j.euf.2017.01.004"},{"issue":"4","key":"2404_CR41","doi-asserted-by":"publisher","first-page":"e19059","DOI":"10.1371\/journal.pone.0019059","volume":"6","author":"E Hornberg","year":"2011","unstructured":"Hornberg E, Ylitalo EB, Crnalic S, Antti H, Stattin P, Widmark A, Bergh A, Wikstrom P (2011) Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival. PLoS One 6(4):e19059. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0019059","journal-title":"PLoS One"},{"issue":"6","key":"2404_CR42","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1158\/0008-5472.CAN-08-3795","volume":"69","author":"Z Guo","year":"2009","unstructured":"Guo Z, Yang X, Sun F, Jiang R, Linn DE, Chen H, Chen H, Kong X, Melamed J, Tepper CG, Kung HJ, Brodie AM, Edwards J, Qiu Y (2009) A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth. Cancer Res 69(6):2305\u20132313. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-3795","journal-title":"Cancer Res"},{"issue":"8","key":"2404_CR43","doi-asserted-by":"publisher","first-page":"11375","DOI":"10.1007\/s13277-016-4951-z","volume":"37","author":"JJ Munoz","year":"2016","unstructured":"Munoz JJ, Drigo SA, Kuasne H, Villacis RA, Marchi FA, Domingues MA, Lopes A, Santos TG, Rogatto SR (2016) A comprehensive characterization of cell cultures and xenografts derived from a human verrucous penile carcinoma. Tumour Biol 37(8):11375\u201311384. \n                    https:\/\/doi.org\/10.1007\/s13277-016-4951-z","journal-title":"Tumour Biol"},{"issue":"6","key":"2404_CR44","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/his.13429","volume":"72","author":"AL Cubilla","year":"2018","unstructured":"Cubilla AL, Velazquez EF, Amin MB, Epstein J, Berney DM, Corbishley CM, Members of the IPTP (2018) The World Health Organisation 2016 classification of penile carcinomas: a review and update from the International Society of Urological Pathology expert-driven recommendations. Histopathology 72(6):893\u2013904. \n                    https:\/\/doi.org\/10.1111\/his.13429","journal-title":"Histopathology"},{"issue":"4","key":"2404_CR45","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10552-008-9276-9","volume":"20","author":"DM Backes","year":"2009","unstructured":"Backes DM, Kurman RJ, Pimenta JM, Smith JS (2009) Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control 20(4):449\u2013457. \n                    https:\/\/doi.org\/10.1007\/s10552-008-9276-9","journal-title":"Cancer Causes Control"},{"issue":"4","key":"2404_CR46","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0002-9440(10)62506-0","volume":"159","author":"MA Rubin","year":"2001","unstructured":"Rubin MA, Kleter B, Zhou M, Ayala G, Cubilla AL, Quint WG, Pirog EC (2001) Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 159(4):1211\u20131218. \n                    https:\/\/doi.org\/10.1016\/S0002-9440(10)62506-0","journal-title":"Am J Pathol"},{"issue":"1","key":"2404_CR47","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/bjc.2012.583","volume":"108","author":"HT Do","year":"2013","unstructured":"Do HT, Koriyama C, Khan NA, Higashi M, Kato T, Le NT, Matsushita S, Kanekura T, Akiba S (2013) The etiologic role of human papillomavirus in penile cancers: a study in Vietnam. Br J Cancer 108(1):229\u2013233. \n                    https:\/\/doi.org\/10.1038\/bjc.2012.583","journal-title":"Br J Cancer"},{"issue":"4","key":"2404_CR48","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/hed.21974","volume":"34","author":"AK El-Naggar","year":"2012","unstructured":"El-Naggar AK, Westra WH (2012) p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency. Head Neck 34(4):459\u2013461. \n                    https:\/\/doi.org\/10.1002\/hed.21974","journal-title":"Head Neck"},{"issue":"5","key":"2404_CR49","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/ijc.30516","volume":"140","author":"ES Prigge","year":"2017","unstructured":"Prigge ES, Arbyn M, von Knebel Doeberitz M, Reuschenbach M (2017) Diagnostic accuracy of p16(INK4a) immunohistochemistry in oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis. Int J Cancer 140(5):1186\u20131198. \n                    https:\/\/doi.org\/10.1002\/ijc.30516","journal-title":"Int J Cancer"},{"issue":"2","key":"2404_CR50","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/PAS.0b013e318203cdba","volume":"35","author":"AL Cubilla","year":"2011","unstructured":"Cubilla AL, Lloveras B, Alejo M, Clavero O, Chaux A, Kasamatsu E, Monfulleda N, Tous S, Alemany L, Klaustermeier J, Munoz N, Quint W, de Sanjose S, Bosch FX (2011) Value of p16(INK)(4)(a) in the pathology of invasive penile squamous cell carcinomas: a report of 202 cases. Am J Surg Pathol 35(2):253\u2013261. \n                    https:\/\/doi.org\/10.1097\/PAS.0b013e318203cdba","journal-title":"Am J Surg Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-018-2404-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-018-2404-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-018-2404-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T19:22:35Z","timestamp":1565464955000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-018-2404-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,11]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["2404"],"URL":"https:\/\/doi.org\/10.1007\/s00428-018-2404-3","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,11]]},"assertion":[{"value":"27 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Institutional Human Research Ethics Committee (Barretos Cancer Hospital) approved the study (Protocol 363-2010).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}